- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2005
- Public Summary Document (PSD) November 2005 PBAC Meeting - PDF
Risperidone – November 2005
Risperidone, tablets, 1 mg, 2 mg, 3 mg and 4 mg; oral disintegrating tablets, 1 mg and 2 mg, Quicklet®; oral solution, 1 mg per mL, Risperdal®, November 2005
Last updated
27 February 2006
